Macromolecules
ARTICLE
access to such nanoparticles. Herein we describe the synthesis of
rylene dyes functionalized with two or more phenyl TFVE
moieties and the fabrication of rylene nanoparticles via a thermal
emulsion polymerization.
1F), -126.69 (dd, J = 109, 98 Hz, 1F), -134.47 (dd, J = 109, 60 Hz, 1F).
UV-vis (CHCl3): λmax (log ε) = 400 (3.8), 558 (4.0), 592 (4.3). HRMS
(ESI, m/z): [M þ H]þ calcd for C72H55F12N2O8, 1303.3767; found,
1303.3769.
M4. Isolated in 74% as a greenish-blue solid from 6 following the
1
procedure described above. H NMR (400 MHz, CDCl3, δ): 8.37 (s,
’ MATERIALS AND METHODS
4H), 7.98 (s, 4H), 7.56 (d, J = 8.4 Hz, 8H), 7.27 (t, J = 4.8 Hz, 2H), 7.23
(d, J = 8.4 Hz, 8H), 7.01 (d, J = 4.8 Hz, 4H), 2.68 (m, 4H), 1.08 (s, 24H).
13C NMR (100 MHz, CDCl3, δ): 163.3, 155.0, 153.2, 147.8, 145.8,
134.6, 132.1, 132.0, 129.7, 129.2, 129.2, 129.0,128.9, 128.4, 127.4, 127.3,
126.1, 125.8, 125.5, 124.1, 123.4, 122.7, 122.0, 119.3, 34.7, 29.2, 21.6. 19F
NMR (376 MHz, CDCl3, δ): -119.00 (dd, J = 98, 60 Hz, 1F), -126.69
(dd, J = 109, 98 Hz, 1F), -134.47 (dd, J = 109, 60 Hz, 1F). UV-vis
(CHCl3): λmax (log ε) = 410 (3.0), 610 (3.1), 665 (3.7), 720 (3.9).
HRMS (ESI, m/z): [M þ H]þ calcd for C90H59F12N2O8, 1523.4080;
found, 1523.1520.
General Procedure for the Synthesis of M3 and M5. A flame-
dried 50 mL Schlenk flask was charged with the appropriate rylene
bromide, 5 (1.1 equiv per bromine substituent), and anhydrous post-
assium carbonate (1.1 equiv per bromine substituent) under a positive
flow of argon. Dry, degassed N-methyl-2-pyrrolidone (10 mL) was
introduced via cannula addition, and the resulting mixture was heated at
80 °C for 12 h. The reactionwas cooledto room temperature, diluted with
1 M HCl, andextractedwithCHCl3 (3 ꢀ 30 mL). Theorganiclayers were
combined and dried over magnesium sulfate, and the solvent evaporated
under reduced pressure. The resulting residue was purified by flash
column chromatography using 60/40 hexanes/dichloromethane as the
eluent.
M3. Isolated in 85% as a deep red solid from 4 following the
procedure described above. 1H NMR (400 MHz, CDCl3, δ): 9.47 (d,
J = 8.4 Hz, 2H), 8.57 (d, J = 8.4 Hz, 2H), 8.23 (s, 1H), 7.18 (m, 8H), 4.04
(m, 4H), 1.87 (m, 2H), 1.57 (s, 4H), 1.28 (m, 22H), 0.88 (m, 16H). 13C
NMR (100 MHz, CDCl3, δ): 163.7, 155.3, 139.4, 132.1, 130.5, 129.3,
129.0, 125.3, 124.1, 123.9, 122.4, 121.3, 118.3, 44.5, 38.1, 30.9, 28.9, 24.2,
23.2, 14.3, 10.8. 19F NMR (376 MHz, CDCl3, δ): -119.00 (dd, J = 98,
60 Hz, 1F), -126.69 (dd, J = 109, 98 Hz, 1F), -134.47 (dd, J = 109, 60
Hz, 1F). UV-vis (CHCl3): λmax (log ε) = 400 (3.8), 461 (3.8), 502
(4.1), 536 (4.4). HRMS (ESI, m/z): [M þ H]þ calcd for
C56H49F6N2O8, 991.3393; found, 991.3398.
General Considerations. Synthetic manipulations were carried
out under argon using dry solvents and standard Schlenk techniques. All
solvents were of ACS reagent grade or better unless otherwise noted.
1,4-Dioxane and 1,2-dimethoxyethane were purified by distillation over
activated alumina. Silica gel (40-63 μm) was obtained from SiliCycle
Inc. Pd2(dba)3 CHCl3 and S-Phos were purchased from Strem Chem-
3
icals and used without further purification. Tetraglyme was purchased
from VWR and purified by passing through a plug of activated neutral
alumina. Compounds 2,15 3,9c 4,16 5,9c and 617 were synthesized
following published procedures. Ultraviolet-visible absorption spectra
were measured with an Agilent 8453 diode array spectrophotometer and
corrected for background signal with a solvent-filled cuvette. Fluores-
cence spectra were measured on a SPEX Fluorolog-τ3 fluorimeter
(model FL-321, 450 W xenon lamp) using right-angle detection.
Fluorescence lifetimes were measured via frequency modulation using
a Horiba-Jobin-Yvon MF2 lifetime spectrometer equipped with a
365 nm laser diode and using the modulation of POPOP as a calibration
reference. Mesitylene/tetraglyme biphasic mixtures were emulsified
with either an IKA Ultra-Turrax T25 Basic high-shear disperser (at a
shear rate of 24/min) or a Misonix Microson ultrasonic cell disruptor.
DLS measurements were performed at the MIT Biophysics Instrumen-
tation Facility using a Wyatt Technologies DynaPro Titan dynamic light
scatterer equipped with a 830 nm diode laser. Data were fitted to a
globular protein model, taking into account solvent refractive indices
and viscosities (CHCl3: 0.57 cP at 20 °C; toluene: 0.59 cP at 20 °C;
tetraglyme: 4.1 cP at 20 °C; water: 1.00 cP at 20 °C).
General Procedure for the Synthesis of M1, M2, and M4. A
flame-dried 50 mL Schlenk flask was charged with the appropriate rylene
bromide, 3 (1.5 equiv per bromine substituent), Pd2(dba)3 CHCl3 (0.05
3
equiv), S-Phos (0.2 equiv), and anhydrous postassium phosphate (20
equiv) under a positive flow of argon. Dry, degassed 1,2-dimethoxyethane
(15 mL) was introduced via cannula addition, and the resulting mixture
was heated at 60 °C for 12 h. The reaction was cooled to room
temperature and passed through a Celite plug, and the solvent evaporated
under reducedpressure. Theresulting residuewas purifiedbyflash column
chromatography using 50/50 hexanes/dichloromethane as the eluent.
M1. Isolated in 70% as a deep red solid from 2 following the
procedure described above, with the substitutions of 1,4-dioxane for
1,2-dimethoxyethane and 3.0 M aqueous potassium phosphate for
anhydrous potassium phosphate. 1H NMR (400 MHz, CDCl3, δ):
8.56 (s, 2H), 8.18 (d, J = 8.4 Hz, 2H), 7.80 (d, J = 8.4 Hz, 2H), 7.56 (d, J =
8.0 Hz, 4H), 7.23 (d, J = 8.0 Hz, 4H), 4.11 (m, 4H), 1.92 (m, 2H), 1.55
(s, 6H), 1.32 (m, 20H), 0.91 (m, 14H). 13C NMR (100 MHz, CDCl3,
δ): 163.8, 139.9, 139.4, 136.8, 136.1, 135.0, 131.1, 130.3, 130.1, 129.8
128.6, 122.5, 121.4, 117.8, 44.5, 38.1, 30.9, 28.9, 24.2, 23.2, 14.3, 10.8. 19F
NMR (376 MHz, CDCl3, δ): -119.00 (dd, J = 98, 60 Hz, 1F), -126.69
(dd, J = 109, 98 Hz, 1F), -134.47 (dd, J = 109, 60 Hz, 1F). UV-vis
(CHCl3): λmax (log ε) = 400 (3.8), 475 (3.2), 519 (4.0), 553 (4.4).
HRMS (ESI, m/z): [M þ H]þ calcd for C56H49F6N2O6, 959.3495;
found, 959.3493.
M5. Isolated in 87% as a deep blue solid from 6 following the
1
procedure described above. H NMR (400 MHz, CDCl3, δ): 9.47 (s,
4H), 8.27 (s, 4H), 7.40 (d, J = 8.4 Hz, 8H), 7.27 (t, J = 4.8 Hz, 2H), 7.09
(d, J = 8.4 Hz, 8H), 7.01 (d, J = 4.8 Hz, 4H), 2.68 (m, 4H), 1.08 (s, 24H).
13C NMR (100 MHz, CDCl3, δ): 163.3, 155.0, 153.2, 147.8, 145.8,
134.6, 132.1, 132.0, 129.7, 129.2, 129.2, 129.0,128.9, 128.4, 127.4, 127.3,
126.1, 125.8, 125.5, 124.1, 123.4, 122.7, 122.0, 119.3, 34.7, 29.2, 21.6. 19F
NMR (376 MHz, CDCl3, δ): -119.00 (dd, J = 98, 60 Hz, 1F), -126.69
(dd, J = 109, 98 Hz, 1F), -134.47 (dd, J = 109, 60 Hz, 1F). UV-vis
(CHCl3): λmax (log ε) = 410 (3.2), 569 (3.8), 623 (4.0), 680 (4.2).
HRMS (ESI, m/z): [M þ H]þ calcd for C90H59F12N2O12, 1587.3876;
found, 1587.3877.
Nanoparticle Synthesis. 0.5 mL of a solution of the appropriate
TFVE-functionalized rylene diimide monomer in mesitylene (0.2-1.6
mg/mL) was added to 5.0 mL of tetraglyme. The resulting biphasic
mixture was either homogenized with a high-shear disperser or sonicated
to yield a homogeneous emulsion, which was then heated to 190 °C
under argon for 12 h.
M2. Isolated in 50% as a deep red solid from 2 following the
1
procedure described above. H NMR (400 MHz, CDCl3, δ): 8.29 (s,
’ RESULTS AND DISCUSSION
4H), 7.56 (d, J = 8.0 Hz, 8H), 7.23 (d, J = 8.0 Hz, 8H), 4.11 (m, 4H), 1.92
(m, 2H), 1.55 (s, 6H), 1.32 (m, 20H), 0.91 (m, 14H). 13C NMR (100
MHz, CDCl3, δ): 163.7, 139.8, 139.4, 136.8, 135.8, 135.0, 131.1, 130.3,
130.1, 128.6, 122.5, 121.4, 117.8, 44.5, 38.1, 30.9, 28.9, 24.2, 23.2, 14.3,
10.8. 19F NMR (376 MHz, CDCl3, δ): -119.00 (dd, J = 98, 60 Hz,
Monomer Synthesis. PDIs were bay-functionalized with
phenyl TFVE moieties starting from either tetrabromide 215 or
dibromide 416 (Scheme 1). Following the previously reported
synthesis and CsF/Ag2O-mediated tetraarylation of 2,15 we
2277
dx.doi.org/10.1021/ma2000866 |Macromolecules 2011, 44, 2276–2281